Table 1 Baseline characteristics of all patients with melanoma and number of deaths according to the time of death following diagnosis.
From: Causes of death among patients with cutaneous melanoma: a US population-based study
Stage | Group | Patients, No | Timing of deaths after diagnosis, No. (%) | ||||
|---|---|---|---|---|---|---|---|
All Years | < 1 years | 1 to < 5 years | 5 to < 10 years | ≥ 10 years | |||
All | Stage | ||||||
Localized | 194,075 | 41,859 (100) | 3057 (7.3) | 17,571 (42) | 13,075 (31.2) | 8156 (19.5) | |
Regional | 21,079 | 10,637 (100) | 1697 (16) | 6568 (61.7) | 1732 (16.3) | 640 (6) | |
Distant | 9470 | 7614 (100) | 5043 (66.2) | 2262 (29.7) | 241 (3.2) | 68 (0.9) | |
Localized | Age, years | ||||||
< 50 | 56,973 | 3108 (100) | 100 (3.2) | 1211 (39) | 1060 (34.1) | 737 (23.7) | |
50–64 | 64,932 | 7804 (100) | 344 (4.4) | 2937 (37.6) | 2505 (32.1) | 2018 (25.9) | |
> 64 | 72,170 | 30,947 (100) | 2613 (8.4) | 13,423 (43.4) | 9510 (30.7) | 5401 (17.5) | |
Sex | |||||||
Male | 106,865 | 27,606 (100) | 2062 (7.5) | 11,892 (43.1) | 8599 (31.1) | 5053 (18.3) | |
Female | 87,210 | 14,253 (100) | 995 (7) | 5,679 (39.8) | 4476 (31.4) | 3103 (21.8) | |
Race | |||||||
White | 191,940 | 41,353 (100) | 3016 (7.3) | 17,331 (41.9) | 12,924 (31.3) | 8,082 (19.5) | |
Black | 621 | 200 (100) | 15 (7.5) | 101 (50.5) | 61 (30.5) | 23 (11.5) | |
API | 1104 | 231 (100) | 21 (9.1) | 108 (46.8) | 69 (29.9) | 33 (14.3) | |
AIAN | 410 | 75 (100) | 5 (6.7) | 31 (41.3) | 21 (28) | 18 (24) | |
Primary site | |||||||
Face/ear | 23,963 | 8302 (100) | 728 (8.8) | 3651 (44) | 2536 (30.5) | 1387 (16.7) | |
Scalp and neck | 14,049 | 4153 (100) | 376 (9.1) | 1942 (46.8) | 1222 (29.4) | 613 (14.8) | |
Trunk | 67,410 | 12,847 (100) | 831 (6.5) | 5207 (40.5) | 4086 (31.8) | 2723 (21.2) | |
Upper limb and shoulder | 51,911 | 11,084 (100) | 766 (6.9) | 4508 (40.7) | 3554 (32.1) | 2256 (20.4) | |
Lower limb and hip | 36,000 | 5276 (100) | 330 (6.3) | 2171 (41.1) | 1627 (30.8) | 1148 (21.8) | |
Other Sites | 742 | 197 (100) | 26 (13.2) | 92 (46.7) | 50 (25.4) | 29 (14.7) | |
Treatment | |||||||
Surgery | 187,913 | 40,360 (100) | 2730 (6.8) | 16,900 (41.9) | 12,722 (31.5) | 8008 (19.8) | |
Radiation | 503 | 271 (100) | 32 (11.8) | 164 (60.5) | 62 (22.9) | 13 (4.8) | |
Chemotherapy | 608 | 358 (100) | 66 (18.4) | 205 (57.3) | 63 (17.6) | 24 (6.7) | |
Regional | Age, years | ||||||
< 50 | 5708 | 1881 (100) | 200 (10.6) | 1212 (64.4) | 352 (18.7) | 117 (6.2) | |
50–64 | 6735 | 2926 (100) | 387 (13.2) | 1895 (64.8) | 471 (16.1) | 173 (5.9) | |
> 64 | 8636 | 5830 (100) | 1110 (19) | 3461 (59.4) | 909 (15.6) | 350 (6) | |
Sex | |||||||
Male | 13,188 | 7,039 (100) | 1153 (16.4) | 4409 (62.6) | 1099 (15.6) | 378 (5.4) | |
Female | 7891 | 3,598 (100) | 544 (15.1) | 2159 (60) | 633 (17.6) | 262 (7.3) | |
Race | |||||||
White | 20,394 | 10,257 (100) | 1651 (16.1) | 6302 (61.4) | 1683 (16.4) | 621 (6.1) | |
Black | 264 | 165 (100) | 22 (13.3) | 116 (70.3) | 18 (10.9) | 9 (5.5) | |
API | 329 | 166 (100) | 17 (10.2) | 118 (71.1) | 24 (14.5) | 7 (4.2) | |
AIAN | 92 | 49 (100) | 7 (14.3) | 32 (65.3) | 7 (14.3) | 3 (6.1) | |
Primary site | |||||||
Face/ear | 2158 | 1173 (100) | 186 (15.9) | 708 (60.4) | 211 (18) | 68 (5.8) | |
Scalp and neck | 2505 | 1460 (100) | 236 (16.2) | 934 (64) | 210 (14.4) | 80 (5.5) | |
Trunk | 6251 | 3116 (100) | 496 (15.9) | 1948 (62.5) | 477 (15.3) | 195 (6.3) | |
Upper limb and shoulder | 4125 | 2030 (100) | 308 (15.2) | 1227 (60.4) | 367 (18.1) | 128 (6.3) | |
Lower limb and hip | 4675 | 2215 (100) | 282 (12.7) | 1408 (63.6) | 389 (17.6) | 136 (6.1) | |
Other sites | 1365 | 643 (100) | 189 (29.4) | 343 (53.3) | 78 (12.1) | 33 (5.1) | |
Treatment | |||||||
Surgery | 19,671 | 9957 (100) | 1445 (14.5) | 6227 (62.5) | 1667 (16.7) | 618 (6.2) | |
Radiation | 1650 | 951 (100) | 194 (20.4) | 597 (62.8) | 121 (12.7) | 39 (4.1) | |
Chemotherapy | 1676 | 1029 (100) | 232 (22.5) | 652 (63.4) | 108 (10.5) | 37 (3.6) | |
Distant | Age, years | ||||||
< 50 | 1868 | 1360 (100) | 873 (64.2) | 441 (32.4) | 38 (2.8) | 8 (0.6) | |
50–64 | 3348 | 2587 (100) | 1714 (66.3) | 771 (29.8) | 83 (3.2) | 19 (0.7) | |
> 64 | 4254 | 3667 (100) | 2456 (67) | 1050 (28.6) | 120 (3.3) | 41 (1.1) | |
Sex | |||||||
Male | 6485 | 5276 (100) | 3524 (66.8) | 1544 (29.3) | 155 (2.9) | 53 (1) | |
Female | 2985 | 2338 (100) | 1519 (65) | 718 (30.7) | 86 (3.7) | 15 (0.6) | |
Race | |||||||
White | 9118 | 7342 (100) | 4881 (66.5) | 2165 (29.5) | 230 (3.1) | 66 (0.9) | |
Black | 153 | 115 (100) | 71 (61.7) | 37 (32.2) | 6 (5.2) | 1 (0.9) | |
API | 174 | 138 (100) | 85 (61.6) | 50 (36.2) | 3 (2.2) | 0 (0) | |
AIAN | 25 | 19 (100) | 6 (31.6) | 10 (52.6) | 2 (10.5) | 1 (5.3) | |
Primary site | |||||||
Face/ear | 9470 | 7614 (100) | 5043 (66.2) | 2262 (29.7) | 241 (3.2) | 68 (0.9) | |
Scalp and neck | 539 | 420 (100) | 241 (57.4) | 157 (37.4) | 14 (3.3) | 8 (1.9) | |
Trunk | 1393 | 1092 (100) | 697 (63.8) | 346 (31.7) | 41 (3.8) | 8 (0.7) | |
Upper limb and shoulder | 700 | 518 (100) | 297 (57.3) | 192 (37.1) | 25 (4.8) | 4 (0.8) | |
Lower limb and hip | 861 | 648 (100) | 314 (48.5) | 303 (46.8) | 29 (4.5) | 2 (0.3) | |
Other sites | 5543 | 4599 (100) | 3329 (72.4) | 1117 (24.3) | 118 (2.6) | 35 (0.8) | |
Treatment | |||||||
Surgery | 3624 | 2716 (100) | 1395 (51.4) | 1145 (42.2) | 129 (4.7) | 47 (1.7) | |
Radiation | 2540 | 2184 (100) | 1415 (64.8) | 710 (32.5) | 49 (2.2) | 10 (0.5) | |
Chemotherapy | 3188 | 2762 (100) | 2008 (72.7) | 683 (24.7) | 56 (2) | 15 (0.5) | |
